000 | 01955 a2200577 4500 | ||
---|---|---|---|
005 | 20250514170025.0 | ||
264 | 0 | _c20040311 | |
008 | 200403s 0 0 eng d | ||
022 | _a0066-4804 | ||
024 | 7 |
_a10.1128/AAC.48.2.525-532.2004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBeyer, Dieter | |
245 | 0 | 0 |
_aNew class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cFeb 2004 |
||
300 |
_a525-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aBacillus subtilis _xdrug effects |
650 | 0 | 4 |
_aBacteria _xdrug effects |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 | _aColony Count, Microbial |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
650 | 0 | 4 |
_aGram-Positive Bacteria _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aPneumococcal Infections _xdrug therapy |
650 | 0 | 4 |
_aProteome _xgenetics |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
650 | 0 | 4 | _aSubstrate Specificity |
700 | 1 | _aKroll, Hein-Peter | |
700 | 1 | _aEndermann, Rainer | |
700 | 1 | _aSchiffer, Guido | |
700 | 1 | _aSiegel, Stephan | |
700 | 1 | _aBauser, Marcus | |
700 | 1 | _aPohlmann, Jens | |
700 | 1 | _aBrands, Michael | |
700 | 1 | _aZiegelbauer, Karl | |
700 | 1 | _aHaebich, Dieter | |
700 | 1 | _aEymann, Christine | |
700 | 1 | _aBrötz-Oesterhelt, Heike | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 2 _gp. 525-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.2.525-532.2004 _zAvailable from publisher's website |
999 |
_c14467077 _d14467077 |